Exact Mass: 500.2046
Exact Mass Matches: 500.2046
Found 221 metabolites which its exact mass value is equals to given mass value 500.2046
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Austin
Austin is a mycotoxin produced by the food storage mould (Aspergillus ustus). These are sesquiterpenes containing a lactone ring. Mycotoxin production by the food storage mould (Aspergillus ustus).
Galactoarabinan
L-Tyrosine, N-(2-(methoxycarbonyl)phenyl)-O-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl)-
Orbiculin D
A dihydroagarofuran sesquiterpenoid that consists of dihydro-beta-agarofuran substituted by acetoxy group at position 1 and furoyloxy groups at positions 6 and 9 (the 1beta,6alpha,9alpha stereoisomer). Isolated from Celastrus orbiculatus, it exhibits inhibition of both NF-kappaB activation and nitric oxide production.
(3S)-3,7-anhydro-6,7-dehydroericanone 4-beta-D-glucopyranoside
(1R,4S,5R,6R,7R,8R)-3-Oxo-8-<5-(5-acetoxytiglyloxy)-tiglyloxy>-guaia-10(14),11(13)-dien-6,12-olide|(1R,4S,5R,6R,7R,8R)-3-Oxo-8-[5-(5-acetoxytiglyloxy)-tiglyloxy]-guaia-10(14),11(13)-dien-6,12-olide
Dodoviscin A
dodoviscin A is a natural product found in Dodonaea viscosa with data available.
cipatrijugin G|methyl rel-[(4R,4aS,6R,7aR,8S,11aS,12aR)-4-(furan-3-yl)dodecahydro-6-hydroxy-4a,7a,9,9-tetramethyl-13-methylidene-2,7,10-trioxo-4H-6,12a-methanopyrano[4,3-b][1]benzoxocin-8-yl]acetate
Dodovisone B
Cys Glu His Ile
Cys Glu His Leu
Cys Glu Ile His
Cys Glu Leu His
Cys His Glu Ile
Cys His Glu Leu
Cys His Ile Glu
Cys His Leu Glu
Cys Ile Glu His
Cys Ile His Glu
Cys Leu Glu His
Cys Leu His Glu
Asp His Met Val
Asp His Val Met
Asp Met His Val
Asp Met Val His
Asp Val His Met
Asp Val Met His
Glu Cys His Ile
Glu Cys His Leu
Glu Cys Ile His
Glu Cys Leu His
Glu His Cys Ile
Glu His Cys Leu
Glu His Ile Cys
Glu His Leu Cys
Glu Ile Cys His
Glu Ile His Cys
Glu Leu Cys His
Glu Leu His Cys
Phe Phe Gly Met
Phe Phe Met Gly
Phe Gly Phe Met
Phe Gly Met Phe
Phe Met Phe Gly
Phe Met Gly Phe
Gly Phe Phe Met
Gly Phe Met Phe
Gly Met Phe Phe
His Cys Glu Ile
His Cys Glu Leu
His Cys Ile Glu
His Cys Leu Glu
His Asp Met Val
His Asp Val Met
His Glu Cys Ile
His Glu Cys Leu
His Glu Ile Cys
His Glu Leu Cys
His Ile Cys Glu
His Ile Glu Cys
His Leu Cys Glu
His Leu Glu Cys
His Met Asp Val
His Met Val Asp
His Val Asp Met
His Val Met Asp
Ile Cys Glu His
Ile Cys His Glu
Ile Glu Cys His
Ile Glu His Cys
Ile His Cys Glu
Ile His Glu Cys
Leu Cys Glu His
Leu Cys His Glu
Leu Glu Cys His
Leu Glu His Cys
Leu His Cys Glu
Leu His Glu Cys
Met Asp His Val
Met Asp Val His
Met Phe Phe Gly
Met Phe Gly Phe
Met Gly Phe Phe
Met His Asp Val
Met His Val Asp
Met Val Asp His
Met Val His Asp
Val Asp His Met
Val Asp Met His
Val His Asp Met
Val His Met Asp
Val Met Asp His
Val Met His Asp
(2S)-3-hydroxy-2-[[1-[[(2R)-2-[(1R)-2-methoxy-2-oxo-1-phenylethyl]piperidine-1-carbonyl]oxymethyl]pyridin-1-ium-3-carbonyl]amino]propanoic acid
(2S)-2-[(4R,5S)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[[(4R,5S)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
(2R)-2-[(4S,5R)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[[(4R,5S)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(4S,5S)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(4S,5R)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(4S,5R)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
2-[(1S,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclohexylacetamide
(2S)-2-[(4S,5R)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5S)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[[(4R,5R)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(4S,5S)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(4R,5R)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
9-(2-Carboxy-4-isothiocyanatophenyl)-3,6-bis(diethylamino)xanthylium
ELN-441958
ELN-441958 is a potent, neutral, competitive and selective bradykinin B1 receptor antagonist with a Ki of 0.26 nM against native human bradykinin B1 receptor. ELN-441958 has high oral bioavailability, and has low CNS exposure in the mouse[1].
(1s,2s,3r,7s,8s,9r,13s)-3,8-dimethyl-13-{[(2z)-2-methylbut-2-enoyl]oxy}-12-methylidene-4,11-dioxo-10-oxatricyclo[7.3.1.0³,⁷]tridec-5-en-2-yl (2z)-2-[(acetyloxy)methyl]but-2-enoate
3,9-dihydroxy-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl 2-methylbut-2-enoate
12'-hydroxy-2,2,2',6',9',13'-hexamethyl-16'-methylidene-6,11',15'-trioxo-10',14'-dioxaspiro[pyran-3,5'-tetracyclo[7.6.1.0¹,¹².0²,⁷]hexadecan]-6'-en-8'-yl acetate
methyl 2-[6-(furan-3-yl)-11-hydroxy-1,5,15,15-tetramethyl-8,14,17-trioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-9-en-16-yl]-2-hydroxyacetate
(8s,9r,10s)-3,9-dihydroxy-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl (2e)-2-methylbut-2-enoate
(6s)-2-[2-(4-hydroxyphenyl)ethyl]-6-[2-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]-5,6-dihydropyran-4-one
27'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione
methyl (2e)-3-[(1s,2r,4s,7s,8s,11r,12s,16r,18r)-7-(furan-3-yl)-18-hydroxy-1,8,15,15-tetramethyl-5,17-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-12-yl]prop-2-enoate
(4r,7r,7ar)-3,7a-dibenzyl-4-hydroxy-4,7-diphenyl-6,7-dihydro-1-benzofuran-2,5-dione
(12'z,18'z,20'z)-6'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione
(8r,9r,10r)-9-hydroxy-3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl but-2-enoate
2-{3-[(2s)-2,3-dihydroxy-3-methylbutyl]-4-hydroxy-5-(3-methylbut-2-en-1-yl)phenyl}-5,7-dihydroxy-3,6-dimethoxychromen-4-one
3,8-dimethyl-13-[(2-methylbut-2-enoyl)oxy]-12-methylidene-4,11-dioxo-10-oxatricyclo[7.3.1.0³,⁷]tridec-5-en-2-yl 2-[(acetyloxy)methyl]but-2-enoate
(1'r,2s,3'r,8'r,12'e,18'e,20'e,24's,25's,27'r)-27'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione
(1'r,2s,3'r,8'r,12'z,18'e,20'z,24's,25's,27'r)-27'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione
(1'r,2r,3'r,8'r,13'r,18'e,20'z,24'r,25's)-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',12',17',22'-tetrone
methyl (2e)-3-[(1s,2r,4s,7s,8s,11r,12s,16r,18s)-7-(furan-3-yl)-18-hydroxy-1,8,15,15-tetramethyl-5,17-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-12-yl]prop-2-enoate
methyl 3-[7-(furan-3-yl)-18-hydroxy-1,8,15,15-tetramethyl-5,17-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-12-yl]prop-2-enoate
methyl 3-[11'-(furan-3-yl)-3'-hydroxy-2',3,3,6',10'-pentamethyl-4',13'-dioxo-12',15'-dioxaspiro[oxirane-2,5'-tetracyclo[8.5.0.0¹,¹⁴.0²,⁷]pentadecan]-6'-yl]prop-2-enoate
atalantin
{"Ingredient_id": "HBIN017265","Ingredient_name": "atalantin","Alias": "NA","Ingredient_formula": "C27H32O9","Ingredient_Smile": "CC1(C2C(=O)C(C3(C(C2(CO1)C=CC(=O)OC)CCC4(C35C(O5)C(=O)OC4C6=COC=C6)C)C)O)C","Ingredient_weight": "500.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1955","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101593045","DrugBank_id": "NA"}